• Kerkhofs TM, Ettaieb MH, Hermsen IG, Haak HR. Developing treatment for adrenocortical carcinoma.
    Endocr Relat Cancer. 2015 Dec;22(6)
  • Fassnacht M et al. Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study.
    Lancet Oncol. 2015 Apr;16(4):426-35.
  • Fassnacht M et al.; FIRM-ACT Study Group.
    Combination chemotherapy in advanced adrenocortical carcinoma.
    N Engl J Med. 2012 Jun 7;366(23):2189-97
  • Baudin E et al. Therapeutic management of advanced adrenocortical carcinoma: what do we know in 2011?
    Horm Cancer 2011 Dec;2(6):363-71
  • Hermsen IG, Groenen YE, Dercksen MW, Theuws J, Haak HR.
    Response to radiation therapy in adrenocortical carcinoma.J Endocrinol Invest. 2010 Nov;33(10):712-4.
  • Sperone et al. Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-/third-line chemotherapy in advanced adrenocortical carcinoma: a multicenter phase II study.
    Endocr Relat Cancer. 2010 Apr 21;17(2):445-53.
  • van Ditzhuijsen CI, van de Weijer R, Haak HR. Adrenocortical carcinoma.
    Neth J Med. 2007 Feb;65(2):55-60.